(Q45806627)

16 December 2017

title

Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6109048

6 August 2023

0 references

D. H. Crawford

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6109048

6 August 2023

P. Sweny

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6109048

6 August 2023

J. M. Edwards

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6109048

6 August 2023

G. Janossy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6109048

6 August 2023

A. V. Hoffbrand

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6109048

6 August 2023

language of work or name

English

0 references

publication date

1 January 1981

1 reference

16 December 2017

3 January 1981

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6109048

full work available at URL

6 August 2023

https://api.elsevier.com/content/article/PII:S014067368190115X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(81)90115-X

https://api.elsevier.com/content/article/PII:S014067368190115X?httpAccept=text/plain

6 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(81)90115-X

6 August 2023

1 reference

16 December 2017

volume

1

1 reference

16 December 2017

issue

8210

1 reference

16 December 2017

page(s)

10-12

1 reference

16 December 2017

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Suppression of in vitro lymphocyte reactivity by cyclosporin A: existence of a population of drug-resistant cytotoxic lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Immunologic phenotype in 30 patients with diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Malignant lymphoma in cyclosporin A treated allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Cyclosporin A immunosuppression, Epstein-Barr antibody, and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Long-term T-cell-mediated immunity to epstein-barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Cyclosporin A and Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Recent progress in Epstein-Barr virus research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990115-X

7 January 2021

Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity

1

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(81)90115-X

6 August 2023

Identifiers

1 reference

16 December 2017

1 reference

16 December 2017